Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement

May 23, 2011 By Bio-Medicine.Org

INDIANAPOLIS, May 23, 2011 /PRNewswire/ — Eli Lilly and Company
(NYSE:
LLY
) today announced that it has signed agreements with private
investors Care Capital and NovaQuest Capital to establish
BioCritica Inc., a newly-formed and privately-held biotechnology
company. BioCritica, based in Central Indiana, will initially focus
on the continued U.S. development and commercialization of
Xigris® (drotrecogin alfa (activated)), Lilly’s medicine for
severe sepsis. BioCritica intends to ultimately build a broad
portfolio of innovative, hospital-based critical care
medicines.

As part of a licensing agreement, BioCritica will acquire the
U.S. development and commercialization rights to Xigris and will
also receive the rights to potentially acquire several critical
care compounds currently in pre-clinical development at Lilly. The
collaboration also includes a supply agreement, a services
agreement and an option for BioCritica to potentially acquire the
development and commercialization rights to Xigris outside the U.S.
at a later date. In return, Lilly will receive royalties on future
U.S. sales of Xigris and will also receive an equity stake in
BioCritica. Specific financial terms of the transaction are not
being disclosed.

The creation of BioCritica received the support of the Indiana
Economic Development Corporation (IEDC) and BioCrossroads,
Indiana’s public-private initiative to grow, advance and invest in
the life sciences. BioCritica’s formation and the Lilly-BioCritica
collaboration are the latest successes in the state’s efforts to
attract new life sciences companies to Central Indiana.  

“We are pleased to announce the formation of a new life sciences
company in Central Indiana, BioCritica. The collaboration between
Lilly and BioCritica will benefit both companies, as well as the
patients we serve and the Indianapolis community in which we
operate,” sai

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech